Pharmacom Microelectronics

Technology Platform

Home

Technology Platform

4S Architecture

Core Technologies

System Development

Core Technology

The company's proprietary technology is an innovative high-throughput screening, detecting and capturing technology for chemical, biochemical and cellular agents. The core technology pools the advantages from:

nanoarray technology which allows nanoscale multi-dimensional analysis;
bioaffinity technology which detects a wide range of molecule-molecule interactions;
molecularly imprinted polymer technology which provides the potential for molecular fabrication, rearrangement and manipulation;
data mining technology which is driven by the algorithms of genomics, proteomics and molecular physicochemical properties;
sensing technology which provides the interface for target-specific microelectrochemical detection.

"MEPFS-SC"

-technology of the cellular fractioning, molecular separation, bioagent sorting

"SSS"

-technology of the microscale DNA sequence determination

"MAIDS"

-technology of the microscale parallel analysis of peptides, nucleotides and small molecules

"LKNMCI"

-technology of the array-based protein identification

"M-POAR"

-technology of the real-time molecule collection and sampling

"DWMPDS"

-technology of the digitalized microprofiling system

Pharmacom Microelectronics